PUROMYCIN
- CAS No.
- 53-79-2
- Chemical Name:
- PUROMYCIN
- Synonyms
- achromycin;Stylomycin;1-mm;3123l;p-638;C01610;cl16536;cl13,900;nsc-3055;PUROMYCIN
- CBNumber:
- CB7152906
- Molecular Formula:
- C22H29N7O5
- Molecular Weight:
- 471.51
- MDL Number:
- MFCD00866328
- MOL File:
- 53-79-2.mol
- MSDS File:
- SDS
- TDS File:
- TDS
| Product description | Number | Pack Size | Price |
| Puromycin ≥95% | 35841 | 1mg | $39 |
| Puromycin ≥95% | 35841 | 5mg | $106 |
| Puromycin ≥95% | 35841 | 10mg | $193 |
| Puromycin 99.55% | CS-6500 | 1mg | $95 |
| Puromycin 99.55% | CS-6500 | 5mg | $239 |
| More product size | |||
| Melting point | 175.5-177° |
|---|---|
| alpha | D25 -11° (ethanol) |
| Boiling point | 572.65°C (rough estimate) |
| Density | 1.3119 (rough estimate) |
| refractive index | 1.7010 (estimate) |
| RTECS | AU7350000 |
| solubility |
DMF: Soluble DMSO: Soluble Ethanol: Soluble Methanol: Soluble |
| pka | 6.8, 7.2(at 25℃) |
| form | Liquid |
| color | White to off-white |
| Water Solubility | Soluble in water (50 mg/ml at 20°C). |
| FDA UNII | 4A6ZS6Q2CL |
| NCI Drug Dictionary | Achromycin |
| EPA Substance Registry System | Adenosine, 3'-[[(2S)-2-amino-3-(4-methoxyphenyl)-1-oxopropyl]amino]-3'-deoxy-N,N-dimethyl- (53-79-2) |
SAFETY
Risk and Safety Statements
| Symbol(GHS) |  GHS07 |
|---|---|
| Signal word | Warning |
| Hazard statements | H302 |
| Precautionary statements | P264-P270-P301+P312a-P330-P501a |
| RIDADR | 3249 |
| HazardClass | 6.1(b) |
| PackingGroup | III |
| Toxicity | LD50 in mice (mg/kg): 350 i.v.; 525 i.p.; 675 orally (Porter, 1952) |
PUROMYCIN price More Price(20)
| Manufacturer | Product number | Product description | CAS number | Packaging | Price | Updated | Buy |
|---|---|---|---|---|---|---|---|
| Cayman Chemical | 35841 | Puromycin ≥95% | 53-79-2 | 1mg | $39 | 2026-04-30 | Buy |
| Cayman Chemical | 35841 | Puromycin ≥95% | 53-79-2 | 5mg | $106 | 2026-04-30 | Buy |
| Cayman Chemical | 35841 | Puromycin ≥95% | 53-79-2 | 10mg | $193 | 2026-04-30 | Buy |
| ChemScene | CS-6500 | Puromycin 99.55% | 53-79-2 | 1mg | $95 | 2026-06-04 | Buy |
| ChemScene | CS-6500 | Puromycin 99.55% | 53-79-2 | 5mg | $239 | 2026-06-04 | Buy |
PUROMYCIN Chemical Properties,Uses,Production
Description
Puromycin is an aminonucleoside antibiotic produced by
Streptomyces alboniger. It is a very common antibiotic routinely
used by scientists in biomedical research to select cells modified
by genetic engineering. It specifically inhibits peptidyl transfer
on both prokaryotic and eukaryotic ribosomes. The antibiotic
inhibits the growth of Gram-positive bacteria and various
animal and insect cells. Fungi and Gram-negative bacteria are
resistant due to the low permeability of the antibiotic. For more
than 30 years, puromycin has been widely used as a basic tool
for studying protein synthesis. Now, puromycin hydrochloride
is particularly useful for the selection of cell types harboring
plasmids carrying puromycin resistance genes. Puromycinresistant
cells express pac gene, which encodes an N-acetyl
puromycin transferase. The pac gene can be mobilized on
a plasmid and used to transfect a host cell in an attempt to
provide resistance; therefore, puromycin can be used in gene
selections for mammalian host cells.
This aminonucleoside antibiotic causes premature chain
termination during translation in the ribosomes. Part of the
molecule resembles the 30 end of the aminoacylated tRNA. It
enters the A site and transfers to the growing chain, causing
premature chain release. The exact mechanism of action is
unknown, but the 30 position contains an amide linkage
instead of the normal ester linkage of tRNA; the amide bond
makes the molecule much more resistant to hydrolysis and
thus causes the ribosome to become stopped. It is not selective
for either prokaryotes or eukaryotes.
Also of note, puromycin is critical in mRNA display as it
allows the growing peptide chain to be covalently bonded to its
own mRNA template. Additionally, puromycin is a reversible
inhibitor of dipeptidyl-peptidase II (serine peptidase) and
cytosol alanyl aminopeptidase (metallopeptidase). The mechanism
of inhibition is not well understood; however, puromycin
can be used to distinguish between aminopeptidase M
(active) and cytosol alanyl aminopeptidase (inhibited by
puromycin) and therefore extremely useful in biochemistry
and nephrology research.
Chemical Properties
Crystals.
Uses
Puromycin has been widely used as a basic tool in research for studying protein synthesis. It is an antibiotic used by scientists in bioresearch to select cells modified by genetic engineering. It inhibits protein synthesis by binding to RNA. It is also an antineoplastic and antitrypanosomal agent.
Uses
Puromycin is a nucleoside antibiotic isolated from Streptomyces alboniger in the 1950s as an anti-trypansomal agent with antibiotic activity. Puromycin is non-selective, inhibiting RNA by blocking ribosomal translation. Puromycin is used in cell biology to select mammalian cell lines that have been transformed by vectors that express puromycin-N-acetyl-transferase.
Uses
Puromycin is an aminonuclease antibiotic produced by the soil actinomyceteStreptomyces alboniger; which induces apoptosis.
Definition
ChEBI: An aminonucleoside antibiotic, derived from the Streptomyces alboniger bacterium, that causes premature chain termination during translation taking place in the ribosome.
Hazard
Toxic to living cells of all kinds.
Toxicity evaluation
Puromycin is a specific metabolic inhibitor of protein synthesis and acts as an aminoacyl-tRNA analog and peptidyl acceptor. The latter causes premature chain termination of the protein and the release of nascent or growing polypeptide chains. In liver, it has been shown to cause fat accumulation without causing death of the hepatocytes. Puromycin causes focal glomerular sclerosis and alters the morphology, localization of anionic sites, and metabolism of renal epithelial cells. This injury is attributable to the production of reactive oxygen species.
References
[1] ABOU-ZEID A. ABOU-ZEID Ahmed I E D Ahmed B Shaheen. Fermentative production of puromycin by Streptomyces alboniger[C]//23 11. 1973: 837-845. DOI: 10.1002/jctb.5020231107
[2] C RODRIGUEZ-FONSECA. Puromycin-rRNA interaction sites at the peptidyl transferase center.[J]. RNA, 2000, 6 5: 744-754. DOI: 10.1017/s1355838200000091
[3] M E AZZAM I D A. Mechanism of puromycin action: fate of ribosomes after release of nascent protein chains from polysomes.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1973, 70 12: 3866-3869. DOI: 10.1073/pnas.70.12.3866
[4] R LÜHRMANN. Localization of the puromycin binding site on the large ribosomal subunit of Escherichia coli by immunoelectron microscopy.[J]. Proceedings of the National Academy of Sciences of the United States of America, 1981, 78 12: 7276-7280. DOI: 10.1073/pnas.78.12.7276
[5] ROHIT SINGH Robert V Jessica Williams. Puromycin based inhibitors of aminopeptidases for the potential treatment of hematologic malignancies[J]. European Journal of Medicinal Chemistry, 2017, 139: Pages 325-336. DOI: 10.1016/j.ejmech.2017.07.048
[6] ROSEMARY M. EKONG . Comparison of the in vitro activities of quassinoids with activity against Plasmodium falciparum, anisomycin and some other inhibitors of eukaryotic protein synthesis[J]. Biochemical pharmacology, 1990, 40 2: Pages 297-301. DOI: 10.1016/0006-2952(90)90691-d
[7] AVINER R. The science of puromycin: From studies of ribosome function to applications in biotechnology.[J]. Computational and structural biotechnology journal, 2020: 1074-1083. DOI: 10.1016/j.csbj.2020.04.014
PUROMYCIN Preparation Products And Raw materials
Raw materials
Preparation Products
| Supplier | Tel | Country | ProdList | Advantage | |
|---|---|---|---|---|---|
| BOC Sciences | +1-631-485-4226 | inquiry@bocsci.com | United States | 19935 | 58 |
| TargetMol Chemicals Inc. | +1-781-999-5354; +1-00000000000 | marketing@targetmol.com | United States | 32431 | 58 |
| Career Henan Chemica Co | +86-0371-86658258 +86-13203830695 | laboratory@coreychem.com | China | 30203 | 58 |
| Hefei TNJ Chemical Industry Co.,Ltd. | +86-0551-65418671 +86-189 4982 3763 | sales@tnjchem.com | China | 34526 | 58 |
| Shaanxi Dideu Medichem Co. Ltd | +86-29-81139210 +86-17392587031 | 1059@dideu.com | China | 9984 | 58 |
| Finetech Industry Limited | +86-27-8746-5837 +86-18627785180 | info@finetechnology-ind.com | China | 9539 | 58 |
| NewCan Biotech Limited | +86-571-86912261 19975279805 | sales@newcanbio.com | China | 9984 | 58 |
| HANGZHOU LEAP CHEM CO., LTD. | +86-571-87711850 +86-15355479329 | market18@leapchem.com | China | 43303 | 58 |
| Shaanxi Dideu New Materials Co. Ltd | 18192503167 | 1036@dideu.com | China | 13244 | 58 |
| NANJING YINGWEN BIOTECHNOLOGY CO LTD | +86-13382787392 | sales@aeechem.com | China | 10000 | 58 |
View Lastest Price from PUROMYCIN manufacturers
| Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
|---|---|---|---|---|---|---|---|---|
 |
2026-08-15 | Puromycin
53-79-2
|
$71.00 | 99.27% | 10g | TargetMol Chemicals Inc. | ||
 |
2026-06-30 | PUROMYCIN
53-79-2
|
1kg | 98% | 1000kg | Shaanxi Dideu New Materials Co. Ltd | ||
 |
2025-06-27 | PUROMYCIN
53-79-2
|
1KG | 99% | 500000kg | Hebei Chuanghai Biotechnology Co., Ltd |
53-79-2(PUROMYCIN)Related Search:
1of4
